UBS Group »

Ngm Biopharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Ngm Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ngm Biopharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ngm Biopharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $72k 45k 1.59
2023-12-31 $41k 47k 0.87
2023-09-30 $24k 22k 1.07
2023-03-31 $12k 2.9k 4.08
2022-12-31 $24k 4.7k 5.02
2021-12-31 $47k 2.7k 17.58
2021-09-30 $17k 807 21.43
2021-06-30 $99k 4.9k 20.00
2021-03-31 $1.2M 42k 29.06
2020-12-31 $554k 18k 30.27
2020-09-30 $196k 12k 15.94
2020-06-30 $189k 9.6k 19.68
2020-03-31 $130k 11k 12.34
2019-12-31 $489k 27k 18.33
2019-09-30 $127k 9.1k 13.90
2019-06-30 $18k 1.2k 14.84